By these arrangements, each of the two arms of the antibody includes one light chain and one heavy chain, with the variable regions at the tips of the Y arms defining antigen specificity.

and whilst the knobs-into-holes technology solves heavy chain mispairing, bYlok® offers an easy to implement solution to address heavy chain-light chain (HC-LC) mispairing. Bispecific antibodies ...

fully human heavy chain-only antibodies that are approximately half the size of conventional IgGs, offering significant ...

US biotech Atossa Therapeutics (Nasdaq: ATOS) has entered into a research collaboration with China-backed Nona Biosciences, ...

Attovia Therapeutics has completed an oversubscribed $90 million Series C financing, which the company plans to use along with existing cash and investments to advance its two lead pipeline candidates ...

fully human heavy chain-only antibodies that are approximately half the size of conventional IgGs, offering significant ...

“Building on Novimmune’s long experience in antibody discovery and development ... a production cell expresses a single heavy chain, alongside κ and λ light chains, which self-assemble ...

Nona Biosciences, a global biotechnology company providing integrated solutions from 'Idea to IND' (I to ITM), ranging from ...

Antibody Solutions, a leading provider of fit-for-purpose antibody discovery services, announced today that for the first time, single plasma B-cell discovery services will be part of the company’s ...

Partnership leverages AbTherx's Atlas Binary Fixed Light Chain Mouse to accelerate Rondo's pipeline of bispecific antibodies MOUNTAIN VIEW, CA / ACCESS Newswire / April 23, 2025 / AbTherx, Inc., a bio ...

Nona Biosciences' proprietary Harbour Mice® platform employs transgenic mice to generate fully human monoclonal antibodies in both the conventional two heavy and two light chain (H2L2 ... to discover ...